Review of Type 2 Diabetes and Anal Fistula Management, 2018-2024

A narrative review synthesizing evidence on the pathophysiological mechanisms and clinical management of type 2 diabetes mellitus complicated with anal fistula. The document, authored by Linhui Li and last updated in April 2026, follows PRISMA 2020 guidelines and systematically searched PubMed, Embase, Cochrane Library, and CNKI for literature from 2018 to June 2024.

Use Cases

• Compare surgical outcomes like healing rates and incontinence risk based on the review of sphincter-preserving techniques.
• Evaluate the efficacy of regenerative therapies such as CGF and MSCs based on reported healing percentages.
• Analyze the impact of preoperative HbA1c levels on postoperative infection rates based on the cited threshold and outcome data.
• Inform the design of multidisciplinary treatment strategies based on synthesized evidence for fistula complexity and glycemic status.

Strengths

• Follows a systematic methodology (PRISMA 2020) for literature review.
• Includes specific outcome metrics, such as a 87.6% long-term healing rate for the TROPIS procedure in diabetic patients.
• Provides concrete clinical targets, like a preoperative HbA1c < 7.0% reducing infection to 8.2%.

Limitations

• The dataset is a 19.0 KB DOCX file, indicating a very limited textual scope rather than primary research data.
• Row count and column-level documentation are absent; the content is a synthesized review.
• The description metadata is limited; actual data quality and primary source accessibility require manual inspection.

Provenance

Source

figshare, authored by Linhui Li.

Collection Method

Systematic literature review following PRISMA 2020 guidelines.

Time Range

Literature covered from 2018 to June 2024.

Freshness

Last updated 2026-04-10 06:00:00; freshness should be verified as the date is in the future relative to typical dataset creation.

Geography

null